Question 1

Has Kaylar Myers received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $4,616 in general payments to Kaylar Myers across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Kaylar Myers did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Kaylar Myers come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	33	$720
ANI Pharmaceuticals, Inc.	43	$591
UCB, Inc.	24	$574
Johnson & Johnson	13	$515
Novartis	17	$481
Amgen	21	$464
Lilly USA, LLC	7	$153
AstraZeneca(2 entities)	5	$134
Pfizer	6	$129
Fresenius Kabi USA, LLC	4	$105
Mallinckrodt Hospital Products Inc.	3	$89
Aurinia Pharma U.S., Inc.	3	$77
Sobi, Inc	3	$74
Pacira Pharmaceuticals Incorporated	3	$67
Organon	3	$66
Boehringer Ingelheim	2	$65
GSK	2	$62
Kiniksa Pharmaceuticals International, PLC	2	$47
Radius Health, Inc.	2	$47
Sanofi	2	$46
Bioventus LLC	1	$35
Genentech USA, Inc.	2	$30
Kyowa Kirin, Inc.	1	$25
E.r. Squibb & Sons, L.L.C.	1	$20

Kaylar Myers

Payments from drug & device makers

Who reported the general payments

How this compares

Other rheumatology in Millersville